| Catalog Number |
5F070301CS |
| Medical Device Problem Code |
Fracture (1260)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
12/04/2024
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
H10: as the lot number for the device was not provided, a review of the device history records could not be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|
| |
|
Event or Problem Description
|
|
It was reported that during a stent placement procedure, the stent allegedly had break.There was no reported patient injury.
|
| |
|
Additional Manufacturer Narrative
|
|
H10: manufacturing review: dhr/bhr review was not requested as the reported lot number is unknown.Investigation summary: no device sample and no x-ray images were provided for evaluation.The reported issue could not be reproduced.Based on information available, the investigation is closed with inconclusive result.A definite root cause for the reported event could not be determined.Labeling review: relevant labeling supplied with this product was reviewed.Potential complications and adverse events which may occur during of the device was found addressed in the instructions for use (ifu); e.G.Stent fracture, stent kinking / collapse, stent migration or stent misplacement.In addition the ifu states: "cases of fracture have been reported in clinical use of the lifestent vascular stent.Cases of stent fracture occurred in lesions that were moderate to severely calcified, proximal or distal to an area of stent overlap and in cases where stents experienced >10% elongation at deployment.Therefore, care should be taken when deploying the stent as manipulation of the delivery system may, in rare instances, lead to stent elongation and subsequent stent fracture." according to the ifu supplied with this product the lifestent 5f vascular stent system is indicated for the treatment of atherosclerotic lesions in the superficial femoral artery (sfa) and popliteal artery.H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|
| |
|
Event or Problem Description
|
|
It was reported that during a stent placement procedure, the stent allegedly had break.There was no reported patient injury.
|
| |
|
Search Alerts/Recalls
|